John E. Kao - Nov 1, 2021 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Role
Chief Executive Officer, Director
Signature
/s/ Richard A. Cross, As Attorney-in-Fact, for John E. Kao
Stock symbol
ALHC
Transactions as of
Nov 1, 2021
Transactions value $
-$1,991,617
Form type
4
Date filed
11/3/2021, 04:56 PM
Previous filing
Oct 15, 2021
Next filing
Nov 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALHC Common Stock Sale -$1.41M -70.7K -1.73% $19.91 4.01M Nov 1, 2021 See Footnote F1, F2, F3
transaction ALHC Common Stock Sale -$584K -29.3K -0.73% $19.93 3.99M Nov 2, 2021 See Footnote F1, F3, F4
holding ALHC Common Stock 311K Nov 1, 2021 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. The reported prices in column 4 are weighted-average prices. The Reporting Person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) and (4) to this Form 4.
F2 The shares were sold in multiple transactions at prices ranging from $19.37 to $20.18 per share.
F3 Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
F4 The shares were sold in multiple transactions at prices ranging from $19.58 to $20.45 per share.
F5 Represents 311,030 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of Alignment Healthcare, Inc., that will vest 25% on the first four anniversaries of the initial vesting date.